Volpe M - Search Results

1

Calcium channel blockers and hypertension.

Tocci G, Battistoni A, Passerini J, Musumeci MB, Francia P, Ferrucci A, Volpe M. Tocci G, et al. Among authors: volpe m. J Cardiovasc Pharmacol Ther. 2015 Mar;20(2):121-30. doi: 10.1177/1074248414555403. Epub 2014 Nov 14. J Cardiovasc Pharmacol Ther. 2015. PMID: 25398848 Review.

2

Do COX-2 inhibitors really prevent hypertension and proteinuria? Another brick in the wall for the COX-2 inhibition and cardiovascular disease controversy.

Cosentino F, Francia P, Volpe M. Cosentino F, et al. Among authors: volpe m. J Hypertens. 2003 Mar;21(3):501-3. doi: 10.1097/00004872-200303000-00013. J Hypertens. 2003. PMID: 12640241 No abstract available.

3

Comparison of the blood pressure-lowering effects and tolerability of Losartan- and Amlodipine-based regimens in patients with isolated systolic hypertension.

Volpe M, Junren Z, Maxwell T, Rodriguez A, Gamboa R, Gomez-Fernandez P, Ortega-Gonzalez G, Matadamas N, Rodriguez F, Dass B, Kyle C, Clarysse L, Bryce A, Moreno-Heredia E, Germano G, Gilles L, Smith RD, Sanderson JE; CDSP-944 Study Group. Volpe M, et al. Clin Ther. 2003 May;25(5):1469-89. doi: 10.1016/s0149-2918(03)80133-9. Clin Ther. 2003. PMID: 12867222 Clinical Trial.

4

Enhanced TNF alpha and oxidative stress in patients with heart failure: effect of TNF alpha on platelet O2- production.

De Biase L, Pignatelli P, Lenti L, Tocci G, Piccioni F, Riondino S, Pulcinelli FM, Rubattu S, Volpe M, Violi F. De Biase L, et al. Among authors: volpe m. Thromb Haemost. 2003 Aug;90(2):317-25. doi: 10.1160/TH03-02-0105. Thromb Haemost. 2003. PMID: 12888880

5

Hypertension therapy: mixing, matching, and meeting targets.

Volpe M. Volpe M. Adv Ther. 2004 Mar-Apr;21(2):107-22. doi: 10.1007/BF02850338. Adv Ther. 2004. PMID: 15310084 Review.

6

Treatment of systolic hypertension: spotlight on recent studies with angiotensin II antagonists.

Volpe M. Volpe M. J Hum Hypertens. 2005 Feb;19(2):93-102. doi: 10.1038/sj.jhh.1001781. J Hum Hypertens. 2005. PMID: 15457205 Review.

7

Beyond hypertension toward guidelines for cardiovascular risk reduction.

Volpe M, Alderman MH, Furberg CD, Jackson R, Kostis JB, Laragh JH, Psaty BM, Ruilope LM. Volpe M, et al. Am J Hypertens. 2004 Nov;17(11 Pt 1):1068-74. doi: 10.1016/j.amjhyper.2004.06.017. Am J Hypertens. 2004. PMID: 15533736

8

Hypertension and heart failure: role of neurohormonal mechanisms.

Volpe M, Pagannone E, Tocci G, Rubattu S. Volpe M, et al. Clin Exp Hypertens. 2004 Oct-Nov;26(7-8):603-10. doi: 10.1081/ceh-200031916. Clin Exp Hypertens. 2004. PMID: 15702614 Free article. Review.

9

Angiotensin-II receptor blockers: benefits beyond blood pressure reduction?

Volpe M, Ruilope LM, McInnes GT, Waeber B, Weber MA. Volpe M, et al. J Hum Hypertens. 2005 May;19(5):331-9. doi: 10.1038/sj.jhh.1001831. J Hum Hypertens. 2005. PMID: 15744333 Review.

10

Angiotensin II type 2 receptors contribute to vascular responses in spontaneously hypertensive rats treated with angiotensin II type 1 receptor antagonists.

Cosentino F, Savoia C, De Paolis P, Francia P, Russo A, Maffei A, Venturelli V, Schiavoni M, Lembo G, Volpe M. Cosentino F, et al. Among authors: volpe m. Am J Hypertens. 2005 Apr;18(4 Pt 1):493-9. doi: 10.1016/j.amjhyper.2004.11.007. Am J Hypertens. 2005. PMID: 15831358

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,386 results

Search Page

Filters